Touchlight, a cell-free DNA innovation company, has announced the commercial launch of mbDNA™ (megabulb DNA), a novel circular single-stranded DNA platform designed to improve non-viral gene editing efficiency across diverse cell types.

Creative Diagnostics has launched a comprehensive range of human hybrid IgM control monoclonal antibodies designed to overcome critical challenges in diagnostic assay development. The new product line addresses the persistent difficulty of sourcing reliable IgM-positive control materials for infectious disease testing across multiple pathogens including CMV, HSV, measles, mumps, rubella, and varicella-zoster virus.

Swiss-American biotech firm Alithea Genomics has launched MERCURIUS™ Total DRUG-seq, an innovative extraction-free transcriptome profiling platform designed to accelerate high-throughput compound screening and target validation through unprecedented multiplexing capabilities. The new library preparation kit represents a significant advancement over the company’s existing MERCURIUS™ 3’ DRUG-seq technology, capturing complete transcriptomes including long non-coding RNAs with full-length […]

Amsbio has introduced GenePORTER Gold, a lipid-based gene transfection reagent designed to deliver exceptional efficiency across a broad spectrum of cell lines whilst minimising cytotoxicity.